The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
CD40 Signaling and Plaque Instability
Open accessAbstract
Today, multiple lines of evidence support the view of atherosclerosis as a chronic inflammatory disease and implicate components of the immune system in atherogenesis. Recent work has documented overexpression of the potent immune mediator CD40 and its counterpart CD40 ligand (CD40L) in experimental and human atherosclerotic lesions. Notably, interruption of CD40/CD40L interactions not only diminished the formation and progression of mouse atheroma, but also fostered changes in lesion biology and structure, which are associated in humans with “plaque stabilization.” In accordance with the hypothesis that CD40 signaling promotes plaque instability, in vitro studies demonstrated that ligation of CD40 on atheroma-associated cell types, namely endothelial cells, smooth muscle cells, and macrophages, mediates functions considered crucial to the process of atherogenesis, such as the expression of cytokines, chemokines, growth factors, matrix metalloproteinases, and procoagulants. The combination of the broad gamut of proatherogenic biological responses triggered by ligation of CD40 on endothelial cells, smooth muscle cells, and macrophages in vitro and the results of in vivo studies of interruption of CD40 signaling suggests a central role for this receptor/ligand dyad during atherogenesis, proposing CD40/CD40L interactions as a novel potential therapeutic target for this prevalent human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Self-citationCD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
Jonasson, L., Holm, J., Skalli, O., Bondjers, G., & Hansson, G. K. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.2.131 · Cited by 1,335
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.-C., Connelly, P. W., & Milstone, D. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11871 · Cited by 1,217
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
Self-citationA Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling
Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856
Kirk, A. D., Burkly, L. C., Batty, D. S., Baumgartner, R. E., Berning, J. D., Buchanan, K., Fechner, J. H., Germond, R. L., Kampen, R. L., Patterson, N. B., et al. (1999) · Nature Medicine · doi:10.1038/9536 · Cited by 826
Yeh, W.-C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., Ferrick, D., Hum, B., Iscove, N., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80391-x · Cited by 798
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Self-citationMach, F., Schönbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1931 · Cited by 732
Self-citationSukhova, G. K., Schönbeck, U., Rabkin, E., Schoen, F. J., Poole, A. R., Billinghurst, R. C., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2503 · Cited by 657
Self-citationAlderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., & Spriggs, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.669 · Cited by 578
Song, H. Y., Régnier, C. H., Kirschning, C. J., Goeddel, D. V., & Rothe, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9792 · Cited by 553
The Structural Biology of Expression and Function of Tissue Factor
Edgington, T. S., Mackman, N., Brand, K., & Ruf, W. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646375 · Cited by 551
Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05530.x · Cited by 511
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
Self-citationCollins, R. G., Velji, R., Guevara, N. V., Hicks, M. J., Chan, L., & Beaudet, A. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.189 · Cited by 493
Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., & Pober, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4342 · Cited by 472
Soluble CD40L and Cardiovascular Risk in Women
Schönbeck, U., Varo, N., Libby, P., Buring, J., & Ridker, P. M. (2001) · Circulation · doi:10.1161/hc4401.099447 · Cited by 459
Self-citationNanki, T., Hayashida, K., El-Gabalawy, H. S., Suson, S., Shi, K., Girschick, H. J., Yavuz, S., & Lipsky, P. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6590 · Cited by 455
Lee, S. Y., Reichlin, A., Santana, A., Sokol, K. A., Nussenzweig, M. C., & Choi, Y. (1997) · Immunity · doi:10.1016/s1074-7613(00)80390-8 · Cited by 445
Requirement for CD154 in the progression of atherosclerosis
Lutgens, E., Gorelik, L., Daemen, M. J. A. P., de Muinck, E. D., Grewal, I. S., Koteliansky, V. E., & Flavell, R. A. (1999) · Nature Medicine · doi:10.1038/15271 · Cited by 439
Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432
Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells
Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/374163a0 · Cited by 413
Expression of functional CD40 by vascular endothelial cells.
Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., & Aruffo, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.33 · Cited by 411
Chemokine Receptors in Human Endothelial Cells
Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., & Stadel, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4282 · Cited by 407
The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3
Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knäuper, V., Docherty, A. J. P., & Murphy, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01528-3 · Cited by 404
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379
Self-citationThe Contributions of Cyclooxygenase-2 to Tumor Angiogenesis
Gately, S. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026575610124 · Cited by 359
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 356
Self-citationStimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes
Kiener, P. A., Moran-Davis, P., Rankin, B. M., Wahl, A. F., Aruffo, A., & Hollenbaugh, D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4917 · Cited by 355
Herman, M. P., Sukhova, G. K., Libby, P., Gerdes, N., Tang, N., Horton, D. B., Kilbride, M., Breitbart, R. E., Chun, M., & Schönbeck, U. (2001) · Circulation · doi:10.1161/hc4101.097419 · Cited by 348
Self-citationAbi-Younes, S., Sauty, A., Mach, F., Sukhova, G. K., Libby, P., & Luster, A. D. (2000) · Circulation Research · doi:10.1161/01.res.86.2.131 · Cited by 312
Self-citationCD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
Van Kooten, C., & Banchereau, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60865-2 · Cited by 311
Ott, I., Fischer, E. G., Miyagi, Y., Mueller, B. M., & Ruf, W. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.1241 · Cited by 301
Cloning of TRAP, a ligand for CD40 on human T cells
Graf, D., Korthäuer, U., Mages, H. W., Senger, G., & Kroczek, R. A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221226 · Cited by 280
Tumor necrosis factor alpha -induced activation of c-jun N-terminal kinase is mediated by TRAF2
Reinhard, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1080 · Cited by 276
Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D., & Chess, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1857 · Cited by 273
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
Lutgens, E., Cleutjens, K. B. J. M., Heeneman, S., Koteliansky, V. E., Burkly, L. C., & Daemen, M. J. A. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7464 · Cited by 271
IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand
Cocks, B. G., de Waal Malefyt, R., Galizzi, J.-P., de Vries, J. E., & Aversa, G. (1993) · International Immunology · doi:10.1093/intimm/5.6.657 · Cited by 255
A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation
Graf, D., Müller, S., Korthäuer, U., van Kooten, C., Weise, C., & Kroczek, R. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250639 · Cited by 249
de Boer, O. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00255-7 · Cited by 241
Kalbas, M., Willuweit, A., Henn, V., Kroczek, R., Müller-Berghaus, G., & Slupsky, J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615402 · Cited by 241
Mueller, B. M., & Ruf, W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci930 · Cited by 234
Oppenheimer-Marks, N., Brezinschek, R. I., Mohamadzadeh, M., Vita, R., & Lipsky, P. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1986 · Cited by 229
IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue
Simonini, A., Moscucci, M., Muller, D. W. M., Bates, E. R., Pagani, F. D., Burdick, M. D., & Strieter, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.13.1519 · Cited by 225
Schecter, A. D., Rollins, B. J., Zhang, Y. J., Charo, I. F., Fallon, J. T., Rossikhina, M., Giesen, P. L. A., Nemerson, Y., & Taubman, M. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28568 · Cited by 223
Musso, T., Calosso, L., Zucca, M., Millesimo, M., Ravarino, D., Giovarelli, M., Malavasi, F., Ponzi, A. N., Paus, R., & Bulfone-Paus, S. (1999) · Blood · doi:10.1182/blood.v93.10.3531.410k32_3531_3539 · Cited by 220
I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.
Rothe, M., Xiong, J., Shu, H. B., Williamson, K., Goddard, A., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8241 · Cited by 212
Majima, M., Hayashi, I., Muramatsu, M., Katada, J., Yamashina, S., & Katori, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703327 · Cited by 203
Melter, M., Reinders, M. E. J., Sho, M., Pal, S., Geehan, C., Denton, M. D., Mukhopadhyay, D., & Briscoe, D. M. (2000) · Blood · doi:10.1182/blood.v96.12.3801 · Cited by 197
CD40 signaling in human dendritic cells is initiated within membrane rafts
Vidalain, P.-O. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3304 · Cited by 186
Patel, S. S., Thiagarajan, R., Willerson, J. T., & Yeh, E. T. H. (1998) · Circulation · doi:10.1161/01.cir.97.1.75 · Cited by 183
CD40-mediated signaling in B cells. Balancing cell survival, growth, and death
Kehry, M. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2345 · Cited by 179
Wagner, D. H., Stout, R. D., & Suttles, J. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241235 · Cited by 178
Mach, F., Schönbeck, U., Fabunmi, R. P., Murphy, C., Atkinson, E., Bonnefoy, J.-Y., Graber, P., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65269-8 · Cited by 175
Self-citationCD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells
Schönbeck, U., Mach, F., Sukhova, G. K., Herman, M., Graber, P., Kehry, M. R., & Libby, P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64699-8 · Cited by 160
Self-citationMiller, D. L., Yaron, R., & Yellin, M. J. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.3.373 · Cited by 158
Schönbeck, U., Mach, F., Sukhova, G. K., Atkinson, E., Levesque, E. B., Herman, M. P., Graber, P., Basset, P., & Libby, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.843 · Cited by 154
Self-citationClark, U. B., Foy, T. M., & Noelle, R. J. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60854-8 · Cited by 153
Dietary Lipid Lowering Reduces Tissue Factor Expression in Rabbit Atheroma
Aikawa, M., Voglic, S. J., Sugiyama, S., Aïkawa, E., Taubman, M. B., Fallon, J. T., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.100.11.1215 · Cited by 153
Self-citationPullen, S. S., Labadia, M. E., Ingraham, R. H., McWhirter, S. M., Everdeen, D. S., Alber, T., Crute, J. J., & Kehry, M. R. (1999) · Biochemistry · doi:10.1021/bi9909905 · Cited by 150
Davis, J. C., Totoritis, M. C., Rosenberg, J., Sklenar, T. A., & Wofsy, D. (2001) · PubMed · Cited by 146
Human Vascular Smooth Muscle Cells Express Receptors for CC Chemokines
Hayes, I., Jordan, N., Towers, S., Smith, G. S. T., Paterson, J. R., Earnshaw, J. J., Roach, A. G., Westwick, J. K., & Williams, R. J. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.3.397 · Cited by 139
Regulation of CD40 function by its isoforms generated through alternative splicing
Tone, M., Tone, Y., Fairchild, P. J., Wykes, M., & Waldmann, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1751 · Cited by 138
Mosca, P. J., Hobeika, A. C., Clay, T. M., Nair, S. K., Thomas, E. K., Morse, M. A., & Lyerly, H. K. (2000) · Blood · doi:10.1182/blood.v96.10.3499 · Cited by 136
Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation
Pinchuk, L. M., Klaus, S. J., Magaletti, D. M., Pinchuk, G. V., Norsen, J., & Clark, E. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4363 · Cited by 135
Polyclonal origin of T lymphocytes in human atherosclerotic plaques.
Stemme, S., Rymo, L., & Hansson, G. K. (1991) · PubMed · Cited by 133
Kashiwada, M., Shirakata, Y., Inoue, J., Nakano, H., Okazaki, K., Okumura, K., Yamamoto, T. S., Nagaoka, H., & Takemori, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.237 · Cited by 125
CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines
Kornbluth, R. S., Kee, K., & Richman, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5205 · Cited by 124
Tsytsykova, A. V., Tsitsikov, E. N., & Geha, R. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3763 · Cited by 124
Aicher, A., Shu, G. L., Magaletti, D. M., Mulvania, T. M., Pezzutto, A., Craxton, A., & Clark, E. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5786 · Cited by 122
Schönbeck, U., Mach, F., Bonnefoy, J., Loppnow, H., Flad, H., & Libby, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19569 · Cited by 119
Self-citationInterleukin-15 Promotes Angiogenesisin Vivo
Angiolillo, A. L., Kanegane, H., Sgadari, C., Reaman, G. H., & Tosato, G. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6435 · Cited by 118
Brossart, P., Zobywalski, A., Grünebach, F., Behnke, L., Stuhler, G., Reichardt, V. L., Kanz, L., & Brugger, W. (2000) · PubMed · Cited by 117
Tissue Factor Induces Migration of Cultured Aortic Smooth Muscle Cells
Sato, Y. Z., Asada, Y., Marutsuka, K., Hatakeyama, K., & Sumiyoshi, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650283 · Cited by 116
Karmann, K., Min, W., Fanslow, W. C., & Pober, J. S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.173 · Cited by 114
Reul, R. M., Fang, J. C.-T., Denton, M., Geehan, C. S., Long, C. G., Mitchell, R. N., Ganz, P., & Briscoe, D. M. (1997) · Transplantation · doi:10.1097/00007890-199712270-00025 · Cited by 113
Pearson, L. L., Castle, B. E., & Kehry, M. R. (2001) · International Immunology · doi:10.1093/intimm/13.3.273 · Cited by 113
Schönbeck, U., Mach, F., & Libby, P. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00016-9 · Cited by 111
Self-citationCD40 Signaling of Monocyte Inflammatory Cytokine Synthesis through an ERK1/2-dependent Pathway
Suttles, J., Milhorn, D. M., Miller, R. W., Poe, J. C., Wahl, L. M., & Stout, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5835 · Cited by 108
NF‐κB activation through IKK‐i‐dependent I‐TRAF/TANK phosphorylation
Nomura, Kawai, T., Nakanishi, K., & Akira, S. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00315.x · Cited by 106
Häkkinen, T., Karkola, K. O., & Ylä‐Herttuala, S. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000239 · Cited by 101
CD154 (CD40L) Induces Human Endothelial Cell Chemokine Production and Migration of Leukocyte Subsets
Thienel, U., Loike, J. D., & Yellin, M. J. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1583 · Cited by 100
Morris, A. E., Remmele, R. L., Klinke, R., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.418 · Cited by 98
Molecular Determinants of Atherosclerotic Plaque Vulnerabilitya
Libby, P., Geng, Y., Sukhova, G. K., Simon, D. I., & Lee, R. T. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51996.x · Cited by 96
Self-citationSchubert, L. A., King, G., Cron, R. Q., Lewis, D. B., Aruffo, A. A., & Hollenbaugh, D. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29624 · Cited by 84
Avice, M.-N., Demeure, C. E., Delespesse, G., Rubio, M., Armant, M. A., & Sarfati, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3408 · Cited by 83
Expression of Interleukin-15 in Mouse and Human Atherosclerotic Lesions
Wuttge, D. M., Eriksson, P. O., Sirsjö, A., Hansson, G. K., & Stemme, S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61712-9 · Cited by 82
Different CD40-mediated signaling events require distinct CD40 structural features
Hostager, B. S., Hsing, Y., Harms, D., & Bishop, G. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1047 · Cited by 81
IL-2 and IL-15 Regulate CD154 Expression on Activated CD4 T Cells
Skov, S., Bonyhadi, M. L., Ødum, N., & Ledbetter, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3500 · Cited by 77
Jabara, H. H., Brodeur, S. R., & Geha, R. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10168 · Cited by 76
Avice, M.-N., Demeure, C. E., Delespesse, G., et al. (1998) · PubMed · Cited by 73
Krzesz, R., Wagner, A. H., Cattaruzza, M., & Hecker, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00683-3 · Cited by 71
Bruemmer, D., Riggers, U., Holzmeister, J., Grill, M., Lippek, F., Settmacher, U., Regitz‐Zagrosek, V., Fleck, E., & Graf, K. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01266-2 · Cited by 64
Hakonarson, H. H., Kim, C., Whelan, R. S., Campbell, D., & GRUNSTEIN, M. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.293 · Cited by 62
Monocyte Chemotactic Protein 1 (MCP-1) Is a Mitogen for Cultured Rat Vascular Smooth Muscle Cells
Porreca, E., Febbo, C. D., Reale, M., Castellani, M. L., Baccante, G., Barbacane, R. C., Conti, P., Cuccurullo, F., & Poggi, A. (2008) · Journal of Vascular Research · doi:10.1159/000159202 · Cited by 61
O’Sullivan, B., MacDonald, K. P. A., Pettit, A. R., & Thomas, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11421 · Cited by 54
Libby, P. (1995) · Nature Medicine · doi:10.1038/nm0195-17 · Cited by 42
Self-citationMurakami, K., Ma, W., Fuleihan, R., & Pober, J. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2667 · Cited by 42
Revy, P., Hivroz, C., Andreu, G., Graber, P., Martinache, C., Fischer, A., & Durandy, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.787 · Cited by 39
Kashiwada, M., Kaneko, Y., Yagita∥, H., Okumura, K., & Takemori, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260708 · Cited by 39
Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma.
Swanson, S. J., Rosenzweig, A., Seidman, J. G., & Libby, P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1210 · Cited by 37
Self-citationJyothi, M. D., & Khar, A. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000151 · Cited by 30
Structure of the murine CD40 ligand gene
Tsitsikov, E. N., Ramesh, N., & Geha, R. S. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90009-4 · Cited by 28
BRADY, K., Fitzgerald, S. N., & Moynagh, P. N. (2000) · Biochemical Journal · doi:10.1042/bj3500735 · Cited by 12
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
Cited by
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
Self-citation
Metadata
- Authors
- Schönbeck, U., & Libby, P.
- Venue
- Circulation Research
- Published
- 2001-12-07
- Volume
- 89
- Issue
- 12
- Pages
- 1092-1103
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2091050865
- Cited by
- 566
- References
- 118
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.